News
The European Commission has approved PTC Therapeutics' treatment for the rare disease phenylketonuria (PKU), Sephience, ...
Cardinal Health, Inc. (NYSE:CAH) is one of the Jim Cramer Reveals Potential US Rare Earth Trump Card & Discusses These 11 ...
Buying $100 In COR: If an investor had bought $100 of COR stock 10 years ago, it would be worth $598.72 today based on a price of $294.12 for COR at the time of writing.
20h
Zacks Investment Research on MSNGEHC Stock Gains Post FDA's Nod for Vizamyl's Expanded IndicationsGE HealthCare Technologies Inc. GEHC has received the FDA’s approval for an updated label for its positron emission ...
Making good on his promise to move with "historic speed and strength", in his first weeks back in office President Donald ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results